Reference  	Reference  	 NN	B-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	I-NP
lymphocyte  	lymphocyte  	 JJ	I-NP
sub-populations  	sub-populations  	 NN	I-NP
in  	in  	 IN	O
healthy  	healthy  	 JJ	O
human  	human  	 JJ	O
immunodeficiency  	immunodeficiency  	 FW	B-NP
virus-negative  	virus-negative  	 FW	I-NP
Iranian  	Iranian  	 FW	O
adults  	adults  	 FW	O
Lymphocyte  	Lymphocyte  	 FW	B-NP
subsets  	subsets  	 FW	I-NP
enumeration  	enumeration  	 FW	I-NP
is  	is  	 VBZ	O
considered  	considered  	 VBN	O
prominent  	prominent  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
management  	management  	 NN	O
of  	of  	 IN	O
primary  	primary  	 JJ	O
and  	and  	 CC	O
acquired  	acquired  	 VBD	O
immunodeficiency  	immunodeficiency  	 JJ	B-NP
disorders 	disorders 	 NNS	I-NP
.  	.  	 .	O
Because  	Because  	 IN	O
of  	of  	 IN	O
local  	local  	 JJ	O
variations  	variations  	 NNS	O
due  	due  	 JJ	O
to  	to  	 TO	O
race 	race 	 NN	O
,  	,  	 ,	O
age 	age 	 NN	O
,  	,  	 ,	O
gender 	gender 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
environmental  	environmental  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
on  	on  	 IN	O
lymphocyte  	lymphocyte  	 JJ	B-NP
subsets 	subsets 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
improve  	improve  	 VB	O
the  	the  	 DT	O
accuracy  	accuracy  	 NN	B-NP
of  	of  	 IN	I-NP
interpretation  	interpretation  	 NN	I-NP
of  	of  	 IN	O
laboratory  	laboratory  	 NN	O
findings 	findings 	 NNS	O
,  	,  	 ,	O
reference  	reference  	 NN	B-NP
intervals  	intervals  	 NNS	I-NP
must  	must  	 MD	O
be  	be  	 VB	O
determined  	determined  	 VBN	O
in  	in  	 IN	O
every  	every  	 DT	O
population 	population 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
establish  	establish  	 VB	O
a  	a  	 DT	O
normal  	normal  	 JJ	B-NP
reference  	reference  	 NN	I-NP
range  	range  	 NN	I-NP
for  	for  	 IN	I-NP
CD3+ 	CD3+ 	 NNP	I-NP
,  	,  	 ,	O
CD4+ 	CD4+ 	 NNP	B-NP
,  	,  	 ,	O
CD8+ 	CD8+ 	 NNP	B-NP
,  	,  	 ,	O
CD19+  	CD19+  	 NNP	B-NP
and  	and  	 CC	O
CD56+  	CD56+  	 CD	B-NP
lymphocytes  	lymphocytes  	 NN	O
in  	in  	 IN	O
a  	a  	 DT	O
healthy  	healthy  	 JJ	O
Iranian  	Iranian  	 JJ	O
adult  	adult  	 NN	B-NP
population  	population  	 NN	I-NP
using  	using  	 VBG	O
flowcytometry 	flowcytometry 	 NNS	B-NP
.  	.  	 .	O
Blood  	Blood  	 NN	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
221  	221  	 CD	O
HIV  	HIV  	 JJ	B-NP
seronegative  	seronegative  	 JJ	I-NP
individuals 	individuals 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
112  	112  	 CD	O
females  	females  	 NNS	O
and  	and  	 CC	O
109  	109  	 CD	O
males 	males 	 NNS	O
,  	,  	 ,	O
with  	with  	 IN	O
ages  	ages  	 NNS	O
ranging  	ranging  	 VBG	O
from  	from  	 IN	O
20  	20  	 CD	O
to  	to  	 TO	O
40  	40  	 CD	O
years  	years  	 NNS	O
old 	old 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
lymphocytes  	lymphocytes  	 JJ	B-NP
expressing  	expressing  	 NN	I-NP
either  	either  	 CC	O
of  	of  	 IN	O
CD3 	CD3 	 NNP	B-NP
,  	,  	 ,	O
CD4 	CD4 	 NNP	B-NP
,  	,  	 ,	O
CD8 	CD8 	 NNP	B-NP
,  	,  	 ,	O
CD19  	CD19  	 NNP	B-NP
and  	and  	 CC	O
CD56  	CD56  	 CD	B-NP
surface  	surface  	 NN	I-NP
markers  	markers  	 NNS	I-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
flowcytometry  	flowcytometry  	 JJ	B-NP
assay 	assay 	 NN	I-NP
.  	.  	 .	O
Total  	Total  	 JJ	B-NP
mean  	mean  	 JJ	I-NP
percentage  	percentage  	 NN	I-NP
and  	and  	 CC	O
absolute  	absolute  	 JJ	O
count  	count  	 NN	O
of  	of  	 IN	O
lymphocyte  	lymphocyte  	 JJ	B-NP
subsets  	subsets  	 NN	I-NP
were  	were  	 VBD	O
as  	as  	 RB	O
follows 	follows 	 VBZ	O
:  	:  	 :	O
CD3+ 	CD3+ 	 CD	B-NP
:  	:  	 :	O
70.90  	70.90  	 CD	O
±  	±  	 CD	O
7.54 	7.54 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
1800.87  	1800.87  	 FW	O
±  	±  	 FW	O
471.09  	471.09  	 FW	O
cells 	cells 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl 	µl 	 FW	I-NP
;  	;  	 :	O
CD4+ 	CD4+ 	 CD	B-NP
:  	:  	 :	O
41.04  	41.04  	 CD	O
±  	±  	 CD	O
7.86 	7.86 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
1039.99  	1039.99  	 FW	O
±  	±  	 FW	O
338.02  	338.02  	 FW	O
cells 	cells 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl 	µl 	 FW	I-NP
;  	;  	 :	O
CD8+ 	CD8+ 	 CD	B-NP
:  	:  	 :	O
31.11  	31.11  	 CD	O
±  	±  	 CD	O
6.60 	6.60 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
783.95  	783.95  	 FW	O
±  	±  	 FW	O
234.87  	234.87  	 FW	O
cells 	cells 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl 	µl 	 FW	I-NP
;  	;  	 :	O
CD19+ 	CD19+ 	 CD	B-NP
:  	:  	 :	O
12.77  	12.77  	 CD	O
±  	±  	 CD	O
4.56 	4.56 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
328.37  	328.37  	 FW	O
±  	±  	 FW	O
153.17  	153.17  	 FW	O
cells 	cells 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl 	µl 	 FW	I-NP
;  	;  	 :	O
CD56+ 	CD56+ 	 CD	B-NP
:  	:  	 :	O
15.53  	15.53  	 CD	O
±  	±  	 CD	O
6.34 	6.34 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
388.62  	388.62  	 FW	O
±  	±  	 FW	O
176.17  	176.17  	 FW	O
cells 	cells 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl 	µl 	 FW	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
ratio  	ratio  	 NN	O
of  	of  	 IN	O
CD4+ 	CD4+ 	 CD	B-NP
/ 	/ 	 CD	O
CD8+  	CD8+  	 CD	B-NP
lymphocytes  	lymphocytes  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
studied  	studied  	 JJ	O
population  	population  	 NN	O
was  	was  	 VBD	O
1.39  	1.39  	 CD	O
±  	±  	 CD	O
0.48 	0.48 	 CD	O
.  	.  	 .	O
Significant  	Significant  	 JJ	B-NP
differences  	differences  	 NNS	I-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
between  	between  	 IN	O
male  	male  	 JJ	O
and  	and  	 CC	O
female  	female  	 JJ	O
subjects  	subjects  	 NNS	B-NP
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
average  	average  	 JJ	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
CD3+  	CD3+  	 CD	B-NP
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
p=0.017 	p=0.017 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
CD4+  	CD4+  	 CD	B-NP
T  	T  	 NN	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
p=0.003 	p=0.003 	 NNP	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
higher  	higher  	 JJR	O
in  	in  	 IN	O
the  	the  	 DT	O
female  	female  	 JJ	O
population 	population 	 NN	O
,  	,  	 ,	O
whereas  	whereas  	 IN	O
the  	the  	 DT	O
average  	average  	 JJ	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
CD19+  	CD19+  	 CD	B-NP
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
p=0.02 	p=0.02 	 NNP	O
)  	)  	 -RRB-	O
tended  	tended  	 VBD	O
to  	to  	 TO	O
be  	be  	 VB	O
higher  	higher  	 JJR	O
among  	among  	 IN	O
males 	males 	 NNS	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
investigations  	investigations  	 NNS	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
CD56+  	CD56+  	 NNP	B-NP
NK  	NK  	 NNP	O
cell  	cell  	 NN	O
and  	and  	 CC	O
CD8+  	CD8+  	 CD	B-NP
T  	T  	 NN	O
cell  	cell  	 NN	O
sub-populations  	sub-populations  	 NN	O
did  	did  	 VBD	O
not  	not  	 RB	O
show  	show  	 VB	O
any  	any  	 DT	O
statistical  	statistical  	 JJ	B-NP
differences  	differences  	 NNS	I-NP
between  	between  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
genders 	genders 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
reports  	reports  	 NNS	O
of  	of  	 IN	O
other  	other  	 JJ	O
populations 	populations 	 NNS	O
,  	,  	 ,	O
we  	we  	 PRP	O
were  	were  	 VBD	O
confronted  	confronted  	 VBN	O
with  	with  	 IN	O
different  	different  	 JJ	O
results 	results 	 NNS	O
.  	.  	 .	O
Establishing  	Establishing  	 VBG	B-NP
reference  	reference  	 NN	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	I-NP
lymphocyte  	lymphocyte  	 JJ	I-NP
subsets  	subsets  	 NN	I-NP
for  	for  	 IN	O
each  	each  	 DT	O
population  	population  	 NN	O
is  	is  	 VBZ	O
helpful  	helpful  	 JJ	O
in  	in  	 IN	O
achieving  	achieving  	 VBG	O
standard  	standard  	 JJ	O
criteria  	criteria  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
prognosis  	prognosis  	 NN	O
of  	of  	 IN	O
HIV  	HIV  	 NNP	B-NP
infection 	infection 	 NN	I-NP
.  	.  	 .	O
Therefore 	Therefore 	 RB	O
,  	,  	 ,	O
normal  	normal  	 JJ	B-NP
ranges  	ranges  	 NNS	I-NP
established  	established  	 VBN	O
by  	by  	 IN	O
this  	this  	 DT	O
survey  	survey  	 NN	O
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
reference  	reference  	 NN	O
for  	for  	 IN	O
decisions  	decisions  	 NNS	O
made  	made  	 VBN	O
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
practice 	practice 	 NN	I-NP
.  	.  	 .	O
